Louisiana Administrative Code
Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS
Part LIII - Pharmacists
Chapter 7 - Pharmacy Interns
Section LIII-703 - Registration
Universal Citation: LA Admin Code LIII-703
Current through Register Vol. 50, No. 9, September 20, 2024
A. All pharmacy interns shall meet the following requirements for registration.
1. All pharmacy interns shall register with
the board. The failure to register may result in disciplinary action by the
board.
a. The applicant shall submit to the
board office a properly completed application no later than the end of the
first semester of the first academic year at a board-approved college of
pharmacy.
b. The board may issue an
intern registration to the applicant, upon receipt of a properly completed
application, appropriate fee, and any other documentation required by the board
office.
c. The intern registration
shall expire one year after the certification of graduation from a
board-approved college of pharmacy.
i. Intern
registrations issued to foreign pharmacy graduates shall expire two years after
the date of issue.
d.
The board shall reserve the right to recall or refuse to issue any intern
registration for cause.
2. A pharmacy intern shall wear appropriate
attire and be properly identified with his name and intern status while on duty
at the preceptor site.
3. A
pharmacy intern shall notify the board in writing within 10 days of a change of
address. This notice shall include the pharmacy interns name, registration
number, and old and new addresses.
4. A pharmacy intern shall notify the board
in writing within 10 days of a change in location(s) of employment. This notice
shall include the pharmacy interns name and registration number, the name and
address of old and new employment, and the permit numbers of those pharmacies
involved.
5. The pharmacy intern
shall be non-impaired.
a. The pharmacy intern
is subject to confidential random drug screen testing and/or
evaluations.
b. A positive drug
screen may be self evident as proof of improper drug use. For the purposes of
this Chapter, a missed screen, a screen submitted beyond the mandated period,
and/or any screen submitted indicating the sample provided is diluted,
substituted, or in any way adulterated is considered to be a positive drug
screen.
AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1211.
Disclaimer: These regulations may not be the most recent version. Louisiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
